We are almost there ...
Adar Poonawalla’s super lucky turn
A look inside the very risky bet that has suddenly made the Serum Institute CEO Indian healthcare’s new, controversial poster boy.
23 April, 2021•12 min
0
23 April, 2021•12 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
Blaming FII selloff for the market fall is lazy, says Shankar Sharma
The veteran investor goes over the recent stock market crash with a fine-tooth comb, analysing whether the market has bottomed out or a bear run is around the corner.
You may also like
Business
News explainers that stood out in 2024
Bluesky vs X, the UAE deluge, Adar Poonawalla’s investment in Karan Johar’s Dharma Productions and more.
Internet
How Bewakoof, once a trendsetter, fell out of favour with young people
Indian youngsters are experimenting with newer D2C brands like never before. Bewakoof’s early success and its 2022 acquisition by retail giant Aditya Birla Fashion should have given it the edge, but the company has been left behind.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.